Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRN | P28799 | 5/20 | 0.49 |
| ▸ | SORT1 | Q99523 | 5/20 | 0.49 |
| ▸ | ACE2 | Q9BYF1 | 4/20 | 0.47 |
| ▸ | ACE | P12821 | 3/20 | 0.47 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | GFER | P55789 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5870485 | 1.00 | GRN (0.49) | GRNSORT1ACE2ACECD274 | |
| SCHEMBL5870491 | 1.00 | GRN (0.49) | GRNSORT1ACE2ACECD274 | |
| SCHEMBL5870482 | 1.00 | GRN (0.49) | GRNSORT1ACE2ACECD274 | |
| SCHEMBL8256384 | 0.92 | SOS1 (0.50) | GRNSORT1ACE2ACEMAPK1 | |
| SCHEMBL5869852 | 0.92 | SOS1 (0.50) | GRNSORT1ACE2ACEMAPK1 | |
| SCHEMBL5869861 | 0.92 | SOS1 (0.50) | GRNSORT1ACE2ACEMAPK1 | |
| SCHEMBL5869847 | 0.92 | SOS1 (0.50) | GRNSORT1ACE2ACEMAPK1 | |
| SCHEMBL5869737 | 0.89 | ALDH1A1 (0.49) | GRNSORT1ACE2ACEALDH1A1 | |
| SCHEMBL5869729 | 0.89 | ALDH1A1 (0.49) | GRNSORT1ACE2ACEALDH1A1 | |
| SCHEMBL5869333 | 0.89 | ALDH1A1 (0.49) | GRNSORT1ACE2ACEALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040082496-A1 | ACE-2 modulating compounds and methods of use thereof | MILLENNIUM PHARMACEUTICALS, INC. | 2004-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040082496-A1 | ACE-2 modulating compounds and methods of use thereof | ACE, ACE2, AGTR2 | GRN 3026/4885SORT1 3962/4885ACE2 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.